Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc

COLL

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.15B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Collegium Pharmaceutical IncCollegium Pharmaceutical Inc14.9-24%1.52.6
$17.40

Current Fair Value

51.3% downside

Overvalued by 51.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.15 Billion
Enterprise Value$1.69 Billion
Dividend Yield$- (-)
Earnings per Share$1.98
Beta0.73
Outstanding Shares32,087,472

Return

Return on Equity23.99%ROE
Return on Assets4.54%
Return on Invested Capital21.81%

Valuation & Multiples

P/E Ratio14.93P/E Ratio
PEG2.99PEG
Price to Sales1.49Price to Sales
Price to Book Ratio3.97Price to Book Ratio
Enterprise Value to Revenue2.12
Enterprise Value to EBIT6.36
Enterprise Value to Net Income22
Total Debt to Enterprise0.48
Debt to Equity2.59Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 14, 2026
EPS Estimate
$1.69
Average shareholder expectation
Revenue Estimate
$186.75 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 6, 2026
EPS Estimate
$1.72
Average shareholder expectation
Revenue Estimate
$199.63 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.43%▼ 116.33%
Total Invested$39.80M▼ 96.83%
Investors Holding57▼ 209.00%

ESG Score

No data

About Collegium Pharmaceutical Inc

CEO: Joseph Ciaffoni